
Allied Healthcare Products AHPI
Annual report 2022
added 10-07-2022
Allied Healthcare Products Total Assets 2011-2026 | AHPI
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Allied Healthcare Products
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.7 M | 17.7 M | 19.7 M | 15.5 M | 17.3 M | 19.6 M | 23.2 M | 25 M | 26 M | 29.3 M | 31.3 M | 31.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.8 M | 15.5 M | 23 M |
Quarterly Total Assets Allied Healthcare Products
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 16.2 M | 15.9 M | 17.1 M | 17.7 M | 18 M | 20 M | 19.7 M | 19.7 M | 16 M | 15.3 M | 15.5 M | 15.5 M | 15.5 M | 17 M | 17.1 M | 17.3 M | 17.3 M | 18.8 M | 19.4 M | 19.6 M | 19.6 M | 20.9 M | 22 M | 22.5 M | 23.2 M | 24.2 M | 24.8 M | 25 M | 25 M | 25.5 M | 26.2 M | 26 M | 26 M | 28.4 M | 29.4 M | 29.3 M | 29.3 M | 30.1 M | 31.1 M | 31.5 M | 31.3 M | 31.5 M | 31.9 M | 31.8 M | 31.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.9 M | 15.3 M | 22.8 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | ||
|
Alphatec Holdings
ATEC
|
791 M | $ 14.07 | 0.21 % | $ 2.11 B | ||
|
Cognyte Software Ltd.
CGNT
|
498 M | $ 6.86 | 3.63 % | $ 493 M | ||
|
ClearPoint Neuro
CLPT
|
39.2 M | $ 13.12 | -13.44 % | $ 355 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
222 M | $ 31.16 | -0.21 % | $ 1.43 B | ||
|
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.49 | -2.18 % | $ 167 M | ||
|
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
43.4 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
79.2 M | $ 3.4 | -0.58 % | $ 118 M | ||
|
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | ||
|
Electromed
ELMD
|
53.8 M | $ 24.27 | 2.1 % | $ 205 M | ||
|
Bio-Rad Laboratories
BIO
|
9.36 B | $ 269.99 | 0.13 % | $ 7.62 B | ||
|
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
5.81 B | $ 40.1 | 0.53 % | $ 5.98 K | ||
|
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
43.7 B | $ 74.86 | 1.87 % | $ 111 B | ||
|
InMode Ltd.
INMD
|
766 M | $ 14.01 | 0.32 % | $ 906 M | ||
|
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | ||
|
IRadimed Corporation
IRMD
|
98.3 M | $ 101.93 | 1.42 % | $ 1.29 B | ||
|
CONMED Corporation
CNMD
|
2.33 B | $ 46.53 | 1.2 % | $ 1.44 B | ||
|
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
2.61 B | $ 70.52 | 0.33 % | $ 3.85 B | ||
|
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
91.7 B | $ 96.9 | 0.25 % | $ 125 B | ||
|
MiMedx Group
MDXG
|
343 M | $ 5.07 | -4.06 % | $ 749 M | ||
|
Delcath Systems
DCTH
|
76.6 M | $ 9.12 | -10.68 % | $ 260 M | ||
|
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
132 M | - | - | $ 10.2 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
210 M | $ 2.44 | -0.41 % | $ 143 M | ||
|
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
347 M | $ 75.24 | -3.9 % | $ 2.12 B | ||
|
Insulet Corporation
PODD
|
3.19 B | $ 251.19 | 1.24 % | $ 17.7 B | ||
|
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | ||
|
Quanterix Corporation
QTRX
|
425 M | $ 6.11 | -2.86 % | $ 230 M | ||
|
FONAR Corporation
FONR
|
199 M | $ 18.55 | -0.19 % | $ 122 M | ||
|
Sintx Technologies
SINT
|
15.4 M | $ 2.9 | -1.36 % | $ 10.8 M | ||
|
Globus Medical
GMED
|
5.3 B | $ 95.66 | -0.58 % | $ 12.9 B |